As of 2024, the average length of stay for hospital treatment of malignant neoplasm of the ovary in France is forecasted at 7.6 days. This shows a declining trend as it is projected to decrease to 7.1 days by 2028. The year-on-year analysis reveals a steady reduction in hospital days, reflecting a consistent annual decrease. In comparison to 2023, there is a visible shift towards shorter stays.
Future trends to watch for include advancements in medical technology and treatments, which may further decrease hospital stays. Additionally, policy changes and healthcare practices focusing on outpatient or less invasive treatments could impact these durations.
